Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL486410 | 0.97 | HRH3 (0.70) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL11179088 | 0.97 | HRH3 (0.70) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL6347703 | 0.97 | HRH3 (0.70) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| Hydrochloric Acid SCHEMBL4710263 | 0.97 | HRH3 (0.62) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL854695 | 0.97 | HRH3 (0.70) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL8554508 | 0.97 | HRH3 (0.70) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL21799578 | 0.95 | HRH3 (0.75) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL5839696 | 0.95 | HRH3 (0.75) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL21799790 | 0.95 | HRH3 (0.75) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 | |
| SCHEMBL21799504 | 0.95 | HRH3 (0.75) | HRH3SMN1; SMN2KEAP1MAPTSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120079215-A | Composite solvent for removing organic sulfur in industrial synthesis gas and preparation method thereof | 远恒(上海)环境科技有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-117915958-A | Dendritic structures as non-viral vectors in gene delivery | 蒂巴生物技术有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116272259-B | Desulfurization and decarbonization solvent suitable for low-pressure gas and application thereof | 四川精事达科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| EP-4313170-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | Tiba Biotech LLC (US) | 2024-02-07 | — | — | EP | claimed |
| CN-116272259-A | Desulfurization and decarbonization solvent suitable for low-pressure gas and application thereof | 四川精事达科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| WO-2022212838-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TIBA BIOTECH LLC (US) | 2022-10-06 | — | — | WO | claimed |
| CN-106914234-B | 'Almond-shaped' Mn2O3Preparation method of/C particles | 广西大学 | 2020-11-06 | — | — | CN | claimed |
| CN-106887606-B | Peach-shaped Mn2O3preparation method of/C particles | 广西大学 | 2019-12-13 | — | — | CN | claimed |
| US-9737875-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-08-22 | — | — | US | claimed |
| EP-1926737-B1 | 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2017-03-15 | — | — | EP | claimed |
| US-20070254896-A1 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-11-01 | — | — | US | claimed |
| WO-2007019884-A1 | NOVEL 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-02-22 | — | — | WO | claimed |
| US-20060122199-A1 | Quinazoline derivatives as src tyrosine kinase inhibitors | ASTRAZENECA AB (SE) | 2006-06-08 | — | — | US | claimed |
| US-20050256154-A1 | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides | LUK KIN-CHUN | 2005-11-17 | — | — | US | claimed |
| EP-1562955-A1 | QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS | Astrazeneca AB (SE) | 2005-08-17 | — | — | EP | claimed |
| WO-2004041829-A1 | QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2004-05-21 | — | — | WO | claimed |
| EP-0614664-B2 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-01-08 | — | — | EP | claimed |
| WO-1999042463-A1 | SUBSTITUTED QUINOXALINE DERIVATIVES AS INTERLEUKIN-8 RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1999-08-26 | — | — | WO | claimed |
| EP-0614664-B1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-09-16 | — | — | EP | claimed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256154-A1 | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides | FGFR3, FGFR4, FGFR1 | HRH3 938/4885SMN1; SMN2 3141/4885KEAP1 3034/4885 |
| US-20060122199-A1 | Quinazoline derivatives as src tyrosine kinase inhibitors | SRC, ABL1, ERBB2 | HRH3 997/4885SMN1; SMN2 3352/4885KEAP1 1652/4885 |
| US-20070254896-A1 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | DTYMK, TK1, DCK | HRH3 2012/4885SMN1; SMN2 2628/4885KEAP1 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.